In another study on lung cancer models, ß2 m blockade by applying CRISPR-Cas resulted in resistance to immune checkpoint inhibitors (ICIs), especially PD-1, proving the effect of HLA-I suppression on the tumor responses to ICIs [105]. This evidence concerns the gene PDCD1 and neoplasm.